<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03339063</url>
  </required_header>
  <id_info>
    <org_study_id>IRENE</org_study_id>
    <nct_id>NCT03339063</nct_id>
  </id_info>
  <brief_title>The Italian REgistry of Pulmonary Non-tuberculous mycobactEria</brief_title>
  <acronym>IRENE</acronym>
  <official_title>The Italian Registry of Pulmonary Non-tuberculous Mycobacteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Niguarda Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera San Gerardo di Monza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ASST Fatebenefratelli Sacco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Policlinico San Matteo Pavia Fondazione IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Spedali Civili di Brescia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>A.O.U. Città della Salute e della Scienza - Molinette Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Unità Locale Socio Sanitaria n.9 Treviso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Maggiore Di Trieste</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria di Modena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Università degli Studi di Ferrara</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero, Universitaria Pisana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria Careggi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale San Jacopo, Pistoia, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Policlinico Universitario Agostino Gemelli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Policlinico Umberto I</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituto Nazionale per le Malattie Infettive Spallanzani, Roma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Policlinico Universitario, Catania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Universitaria Policlinico &quot;G. Martino&quot;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Cosenza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero Universitaria di Sassari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Italian registry of pulmonary non-tuberculous mycobacteria (NTM) -IRENE- is an
      observational, multicenter, prospective, cohort study enrolling consecutive adult patients
      with either a NTM respiratory infection or NTM-Pulmonary Disease. The coordinating center is
      located at the Pulmonary Department of the Fondazione IRCCS Ca' Granda, Ospedale Maggiore
      Policlinico, Milan, Italy. So far, more than 35 centers, including mainly pulmonary and
      infectious disease departments, joined the registry. The registry has been developed to
      accept an unlimited number of patients and no deadlines have been decided.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The epidemiology of patients suffering from a pulmonary disease due to NTM (NTM-PD), which is
      characterized by symptomatic, progressive inflammatory lung damage and defined in 2007 in the
      ATS/IDSA guidelines, still remains unclear. Reporting of NTM-PD to health authorities is
      often not mandated in several countries and the current estimates have been obtained from
      sentinel surveillance or laboratory-based studies, retrospective cohort studies, or audits of
      administrative databases. Until now no data have been published on the epidemiology of
      respiratory NTM infections in Italy.

      The Italian registry of pulmonary NTM (IRENE) is an observational, multicenter, prospective,
      cohort study enrolling consecutive adult patients with either a NTM respiratory infection or
      NTM-PD. The coordinating center is located at the Pulmonary Department of the Fondazione
      IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. So far, more than 35 centers,
      including mainly pulmonary and infectious disease departments, joined the registry. The study
      is sponsored by the Policlinico Hospital in Milan. The study website is located at
      www.registroirene.it.

      Adult (&gt;=18 years) patients with all of the following are included in the registry: 1) at
      least one positive culture for any NTM species from any respiratory sample; 2) at least one
      positive culture for NTM isolated in the year prior the enrolment and/or prescribed NTM
      treatment in the year prior the enrolment; 3) Given consent to inclusion in the study. No
      exclusion criteria are applied to the study. Patients included in the registry are mainly
      recruited among pulmonary and ID out- and in-patient services. Adult cystic fibrosis, lung
      transplant, and tuberculosis clinics represent other recruitment centers. The registry has
      been developed to accept an unlimited number of patients and no deadlines have been decided.

      Patients are managed according to standard operating procedures implemented in each IRENE
      clinical center without any interference from the study team. A baseline case report form is
      collected at patient's enrolment including demographics, comorbidities, microbiological,
      laboratory, functional, radiological, clinical, and treatment data. Then, study investigators
      enter follow-up data on an annual basis.

      An IRENE biobank has also been developed within the network and linked to the clinical data
      of the registry. IRENE sites can collect samples, including blood, serum, plasma, respiratory
      specimens (sputum, induced sputum, tracheal aspirate, or bronchoalveolar lavage), urine, and
      NTM isolates at the first visit and during follow up on a voluntary basis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Proportion of patients meeting the quality standards for NTM-PD care suggested by international guidelines (including the latest ERS 2017 guidelines)</measure>
    <time_frame>5 years</time_frame>
    <description>The number of patients with NTM-PD who have been managed or treated according to the recommendations published by international guidelines</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Nontuberculous Mycobacteria</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sputum Bronchoalveolar lavage Full Blood Serum Urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients included in the registry are mainly recruited among pulmonary and Infectious
        diseases out- and in-patient services. Adult cystic fibrosis, lung transplant, and
        tuberculosis clinics represent other recruitment centers. A heterogeneous population of
        patients with NTM infection/NTM-Pulmonary Disease sharing different clinical phenotypes is
        expected to be enrolled in the registry. IRENE has a special focus on four patients'
        categories: 1) immunocompetent/bronchiectatic, 2) HIV-positive, 3) cystic fibrosis and 4)
        lung transplanted patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (all of them):

          -  Adult (&gt;=18 years) patients

          -  At least one positive culture for any NTM species from any respiratory sample

          -  At least one positive culture for NTM isolated in the year prior the enrolment and/or
             prescribed NTM treatment in the year prior the enrollment

          -  Given consent to inclusion in the study.

        Exclusion Criteria:

        No exclusion criteria are applied to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Aliberti, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Blasi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luigi Ruffo Codecasa, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Regional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Gori, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinic of Infectious Diseases, 'San Gerardo&quot; Hospital-ASST Monza, University Milano-Bicocca, Milano, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefano Aliberti, MD</last_name>
    <phone>+390250320627</phone>
    <email>stefano.aliberti@unimi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinic of Infectious Diseases, 'San Gerardo&quot; Hospital-ASST Monza, University Milano-Bicocca, Milano</name>
      <address>
        <city>Monza</city>
        <state>Monza Brianza</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Gori, MD</last_name>
      <email>andrea.gori@unimib.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malattie Infettive, Alma Mater Studiorum Università di Bologna</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierluigi Viale, MD</last_name>
      <email>pierluigi.viale@unibo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Alma Mater Studiorum Università di Bologna</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefano Nava, MD</last_name>
      <email>stefano.nava@aosp.bo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica di Malattie Infettive e Malattie Tropicali, Spedali Civili di Brescia, Università di Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alberto Matteelli, MD</last_name>
      <email>matteelli@med.unibs.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malattie Infettive, Ospedale Garibaldi-NESIMA di Catania</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Salvatore Tosto, MD</last_name>
      <email>salvotosto56@yahoo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O.C. Malattie Infettive, Azienda Ospedaliera di Cosenza</name>
      <address>
        <city>Cosenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Mastroianni, MD</last_name>
      <email>antoniomastroianni@yahoo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Azienda Ospedaliero-Universitaria di Ferrara</name>
      <address>
        <city>Ferrara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco Contoli, MD</last_name>
      <email>marco.contoli@unife.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dipartimento Medicina Sperimentale e Clinica, SOD Malattie Infettive e Tropicali, Azienda Ospedaliero Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Filippo Bartalesi, MD</last_name>
      <email>bartalesif@aou-careggi.toscana.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malattie Infettive, IRCCS-AOU San Martino</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Di Biagio, MD</last_name>
      <email>adibiagioa@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Aliberti, MD</last_name>
      <phone>+390250320627</phone>
      <email>stefano.aliberti@unimi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malattie Infettive, Ospedale Luigi Sacco</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabio Franzetti, MD</last_name>
      <email>fabio.franzetti@unimi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Ospedale Luigi Sacco</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierachille Santus, PhD</last_name>
      <email>pierachille.santus@unimi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional TB Reference Centre, Istituto Villa Marelli, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luigi Ruffo Codecasa, MD</last_name>
      <phone>+390264445833</phone>
      <email>luigiruffo.codecasa@ospedaleniguarda.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malattie Infettive, Ospedale di Modena</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristina Mussini, MD</last_name>
      <email>cristina.mussini@unimore.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Ospedale di Modena</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabrizio Luppi, MD</last_name>
      <email>fabrizio.luppi@unimore.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angelo Corsico, MD</last_name>
      <email>corsico@unipv.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Ospedale di Pisa</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierluigi Paggiaro, MD</last_name>
      <email>pierluigi.paggiaro@unipi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.O.C. Malattie Infettive II, AUSL Toscana Centro - Pistoia, Ospedale San Jacopo</name>
      <address>
        <city>Pistoia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michele Trezzi, MD</last_name>
      <email>michele.trezzi@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Policlinico Gemelli</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luca Richeldi, MD</last_name>
      <email>Luca.richeldi@policlinicogemelli.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UOC di Medicina Interna e Disfunzioni Respiratorie, Azienda Universitaria Ospedaliera Policlinico Umberto I di Roma</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Palange, MD</last_name>
      <email>paolo.palange@uniroma1.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UOS Day Service Malattia Tubercolare afferente all'UOC Malattie Infettive dell'Apparato Respiratorio, Istituto Nazionale per le Malattie Infettive &quot;L. Spallanzani&quot; - IRCCS</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gina Gualano, MD</last_name>
      <email>gina.gualano@inmi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologia, Dipartimento Di Medicina Clinica e Sperimentale, Università degli studi di Sassari</name>
      <address>
        <city>Sassari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pietro Pirina, MD</last_name>
      <email>pirina@uniss.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Divisione di Pneumologia, AOU Città della Salute e della Scienza di Torino, Molinette</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Solidoro, MD</last_name>
      <email>psolidoro@cittadellasalute.to.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malattie Infettive, Università degli studi di Torino</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Calcagno, MD</last_name>
      <email>andrea.calcagno@unito.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UO di Pneumotisiologia, Ospedale di Vittorio Veneto</name>
      <address>
        <city>Treviso</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefano Nardini, MD</last_name>
      <email>snardini.pneumologo@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Pneumologia, Ospedale Universitario di Cattinara</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marco Confalonieri, MD</last_name>
      <email>marco.confalonieri@aots.sanita.fvg.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov;72(Suppl 2):ii1-ii64. doi: 10.1136/thoraxjnl-2017-210927.</citation>
    <PMID>29054853</PMID>
  </reference>
  <reference>
    <citation>Faverio P, Stainer A, Bonaiti G, Zucchetti SC, Simonetta E, Lapadula G, Marruchella A, Gori A, Blasi F, Codecasa L, Pesci A, Chalmers JD, Loebinger MR, Aliberti S. Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis. Int J Mol Sci. 2016 Nov 16;17(11). pii: E1913.</citation>
    <PMID>27854334</PMID>
  </reference>
  <reference>
    <citation>Bonaiti G, Pesci A, Marruchella A, Lapadula G, Gori A, Aliberti S. Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis. Biomed Res Int. 2015;2015:197950. doi: 10.1155/2015/197950. Epub 2015 May 27. Review.</citation>
    <PMID>26106603</PMID>
  </reference>
  <reference>
    <citation>Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. Review. Erratum in: Am J Respir Crit Care Med. 2007 Apr 1;175(7):744-5. Dosage error in article text.</citation>
    <PMID>17277290</PMID>
  </reference>
  <reference>
    <citation>Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, Noone PG, Bilton D, Corris P, Gibson RL, Hempstead SE, Koetz K, Sabadosa KA, Sermet-Gaudelus I, Smyth AR, van Ingen J, Wallace RJ, Winthrop KL, Marshall BC, Haworth CS; US Cystic Fibrosis Foundation and European Cystic Fibrosis Society. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016 Jan;71 Suppl 1:i1-22. doi: 10.1136/thoraxjnl-2015-207360.</citation>
    <PMID>26666259</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2017</study_first_submitted>
  <study_first_submitted_qc>November 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nontuberculous Mycobacteria</keyword>
  <keyword>Non-tuberculous mycobacteria</keyword>
  <keyword>NTM-PD</keyword>
  <keyword>NTM-LD</keyword>
  <keyword>MAC</keyword>
  <keyword>M. avium</keyword>
  <keyword>M. intracellulare</keyword>
  <keyword>M. abscessus</keyword>
  <keyword>Atypical mycobacteria</keyword>
  <keyword>NTM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycobacterium Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IRENE is the official Italian network within the EMBARC European NTM registry. All Italian patients included in the European NTM registry will be enrolled through IRENE and IRENE data will be incorporated into the European NTM registry.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

